High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator

dc.contributor.author	Sørbye, Sveinung Wergeland
dc.contributor.author	Kilvær, Thomas Karsten
dc.contributor.author	Valkov, Andrey Yurjevich
dc.contributor.author	Dønnem, Tom
dc.contributor.author	Smeland, Eivind
dc.contributor.author	Al-Shibli, Khalid Ibrahim
dc.contributor.author	Bremnes, Roy M.
dc.contributor.author	Busund, Lill-Tove
dc.date.accessioned	2013-03-14T12:56:05Z
dc.date.available	2013-03-14T12:56:05Z
dc.date.issued	2012
dc.description.abstract	The immune status is important in cancer patients. Tissue microarrays from 249 patients with soft tissue sarcomas were constructed. Immunohistochemistry was used to evaluate the CD3+, CD4+, CD8+, CD20+ and CD45+ lymphocytes in tumors. High density of CD20+ lymphocytes is an independent positive prognostic indicator for these patients.	en
dc.identifier.citation	OncoImmunology 1(2012) nr. 1 s. 75-77	en
dc.identifier.cristinID	FRIDAID 931858
dc.identifier.doi	http://dx.doi.org/10.4161/onci.1.1.17825
dc.identifier.uri	https://hdl.handle.net/10037/5023
dc.identifier.urn	URN:NBN:no-uit_munin_4735
dc.language.iso	eng	en
dc.rights.accessRights	openAccess
dc.subject	VDP::Medical disciplines: 700::Clinical medical disciplines: 750::Oncology: 762	en
dc.subject	VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762	en
dc.title	High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator	en
dc.type	Journal article	en
dc.type	Tidsskriftartikkel	en